2025-03-17
BIOPLUS-INTERPHEX KOREA 2025:
Pioneering the Future of Biopharma with Specialized Pavilions
SEOUL, SOUTH KOREA – BIOPLUS-INTERPHEX KOREA (BIX) 2025 is poised to become the main hub of biopharmaceutical innovation, taking place from October 15-17, 2025, at Coex, Seoul. This premier event will gather researchers, specialists, and industry leaders from around the globe to explore groundbreaking advancements that are shaping the future of biopharma.
Showcasing Innovation Through Specialized Pavilions
BIX 2025 will spotlight four specialized pavilions, each dedicated to a critical area of the pharmaceutical sector: Digital Healthcare, CMO/CDMO, Bio Materials/Components/Equipment, and Cold Chain. These pavilions will feature state-of-the-art solutions and attract targeted audiences through strategic promotions.
Digital Healthcare Special Pavilion: Dive into the latest digital health technologies, including telemedicine and AI-driven diagnostics, revolutionizing patient care and healthcare delivery. (Featured exhibitors: AWS, Oracle, Dot Inc and more)
CMO/CDMO Special Pavilion: Uncover the latest trends in contract manufacturing and development, showcasing cutting-edge capabilities in biopharma production. (Featured exhibitors: Lonza, Samsung Biologics, Wuxi, Catalent, Roche and more)
BioMaterials/Components/Equipment Special Pavilion: Engage with innovations in biopharmaceutical materials, parts, and equipment that enhance industry efficiency and effectiveness. (Featured exhibitors: iCell, MicroDigital, MDMune, Biospectrum and more)
Cold Chain Special Pavilion: Discover advanced solutions in cold chain logistics and packaging, ensuring the safe and effective delivery of biopharmaceutical products. (Featured exhibitors: UPS, DB Schenker, World Courier, Envirotainer, CSafe and more)
Opportunities for Global Connections and Insights
BIX 2025 will provide unique opportunities for global connections and insights into emerging trends. With over 30+ specialized conference sessions, attendees will gain valuable knowledge from industry experts on topics ranging from advanced drug delivery systems to state-of-the-art bioprocessing solutions.
Networking and Collaboration
The event will also offer exclusive networking opportunities, including one-on-one partnering meetings and industry-wide collaborations that drive innovation and market growth. Attendees will have the chance to connect with leading companies and decision-makers, fostering strategic partnerships and business expansion.
Don't miss your chance to be part of BIOPLUS-INTERPHEX KOREA 2025. At this platform for growth and collaboration, you can find a place to exhibit your innovations, broaden your global audience, or stay ahead of industry developments.
For exhibitor inquiries and visitor registration, visit [https://www.bioplusinterphex.co.kr/] or contact us at [[email protected]].
BIOPLUS-INTERPHEX KOREA (BIX) is an event organized by KoreaBIO and hosted by RX, the world’s largest event organizer. Covering the entire value chain of the biopharma industry, BIX offers the unique advantage of bringing together various stakeholders from the industry in one place.
About RX
RX is a global leader in events and exhibitions, leveraging industry expertise, data, and technology to build businesses for individuals, communities, and organizations. With a presence in 25 countries across 42 industry sectors, RX hosts approximately 350 events annually. Notably, RX includes the INTERPHEX series, a global event held in both Japan and the US, which highlights its international reach and influence. RX is committed to creating an inclusive work environment for all its people and empowers businesses to thrive by leveraging data-driven insights and digital solutions. RX is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.rxglobal.com.
About KoreaBIO
KoreaBio (Korea Biotechnology Industry Organization) is a key organization in the bioindustry, established under the Industrial Development Act. It strengthens ties within the bioindustry, promotes technological development, and contributes to economic growth. Since 2015, KoreaBIO has organized BIOPLUS to raise the global profile of Korea’s bio-industry. From 2020, BIOPLUS has been held alongside INTERPHEX, a leading platform for biopharma innovation and collaboration.